Clinical Guest Contributors

  1. Heading For An M&A? Understand The Risks And Mitigation Strategies For Clinical Trial Agreements 11/10/2025

    Learn the key considerations to anticipate and mitigate risks that CTAs and diligence in the clinical trial space present during mergers and acquisitions (M&As).

  2. Sites Are 3X Likely To Die In The First Year Than New Businesses 11/7/2025

    Milken Institute Health Director of Research Andrew Friedson, Ph.D., reveals the stark truth of site survivability and discusses how factors like available population and local economic conditions factor into survival rates.

  3. Sponsors Collect Too Much "Non-Essential" Data, Say Tufts And TransCelerate 11/6/2025

    A collaboration between Tufts CSDD, Tufts School of Medicine, and TransCelereate BioPharma revealed just how much extra data sponsors are collecting — and why that's a problem.

  4. Global Implications Of Zero Tariffs On Indian Pharma Exports To China 11/5/2025

    Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.

  5. Behavior Modeling Can Help Sponsors Better Understand Sites And Patients 11/4/2025

    Learn how behavioral modeling can identify patients at risk of dropout and sites that may need additional support, so you can build a more resilient research network.

  6. How The U.S. Can Beat China In Biotech 11/3/2025

    Lumen Bioscience's Brian Finrow breaks down China's biotech playbook and explores ways the U.S. can adapt it for its own continued success.

  7. How AI Is Transforming Patient Stratification 10/31/2025

    Discover how AI tools can help stratify or group patients into subtypes that respond differently to treatment.

  8. The Rise Of Specialist CROs In Clinical Outsourcing 10/30/2025

    Understand the trends behind the growing specialist CRO sector.

  9. How AI Is Rewriting The Future Of TMF And Clinical Quality 10/29/2025

    Discover how AI is transforming the TMF from a reactive repository into a proactive, intelligent co-pilot for clinical trials.

  10. Trends In Rare Disease Trials: Recommendations 10/24/2025

    In the third article of this series, analyst reveal their top 6 recommendations for designing selection criteria and selecting solution options to optimize rare disease research outcomes.